X
Record #68064

Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

Original paper date
Mar 18, 2021
Institution
Tyumen State Medical University, Tyumen, Russian Federation · Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India · Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russia · German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), 69120, Heidelberg, Germany · Faculty Affairs, Taneja College of Pharmacy, University of South Florida, Tampa, FL, USA · Department of Hematology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran · Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran · Cell Therapy and Regenerative Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran · Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cellular(HSC) Medicine - Immunology(HSC) Medicine - Infectious Disease
Notes from Retraction Watch

see also: https://pubpeer.com/publications/BA01B5FC01DF2D637D6875CD32A797

Citation lifecycle

How this paper is being cited

Pre-retraction
152
Same day
1
Post-retraction
49
% post-retraction
24.6%
~49.1 citations/yr before retraction · ~20.4 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse